Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the ultimate goal of improving the way we survive, age, and live. Lanier targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology. Lanier’s lead developments programs include LNR 653.1, a fully humanized anti-VEGF / IL-17A multifunctional antibody for the treatment of retinal neovascularization diseases and LNR 125.36, a fully humanized anti-IL-25 monoclonal antibody for the treatment of Type 2 Inflammatory diseases.
View Top Employees from Lanier Biotherapeutics| Website | http://lanierbio.com |
| Employees | 4 (4 on RocketReach) |
| Address | 150 Ben Burton Rd, Bogart, Georgia 30622, US |
| Industry | Biotechnology Research |
Looking for a particular Lanier Biotherapeutics employee's phone or email?
Lanier Biotherapeutics Questions
Kirby Alton is the Chairman of Lanier Biotherapeutics.
4 people are employed at Lanier Biotherapeutics.
Lanier Biotherapeutics is based in Bogart, Georgia.
Top Lanier Biotherapeutics Employees
-
35
-
53
-
32
-
ViewDaniel White
Co-Founder, President and Chief Executive Officer at Lanier Biotherapeutics
Suwanee, Georgia, United States43
Related Companies
